Prolactin induced increase in neutral stem cell numbers and therapeutical use thereof

Details for Australian Patent Application No. 2002325711 (hide)

Owner Stem Cell Therapeutics Inc.

Inventors Weiss, Samuel; Shingo, Tetsuro

Agent Shelston IP

Pub. Number AU-B-2002325711

PCT Number PCT/CA02/01345

PCT Pub. Number WO2003/024472

Priority 60/322,514 14.09.01 US; 60/386,404 07.06.02 US

Filing date 30 August 2002

Wipo publication date 1 April 2003

Acceptance publication date 23 August 2007

International Classifications

A61L 27/00 (2006.01) Materials for prostheses or for coating prostheses

A61K 31/565 (2006.01) - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61K 35/12 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Materials from mammals or birds

A61K 35/30 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Nerves

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/22 (2006.01) Medicinal preparations containing peptides - Hormones

A61K 38/27 (2006.01) Medicinal preparations containing peptides - Growth hormone (GH) (Somatotropin)

A61K 38/30 (2006.01) Medicinal preparations containing peptides - Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2

A61P 21/00 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/14 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C12N 5/06 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

C12N 5/08 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

Event Publications

23 January 2003 Complete Application Filed

  Priority application(s): 60/322,514 14.09.01 US; 60/386,404 07.06.02 US

5 June 2003 Application Open to Public Inspection

  Published as AU-B-2002325711

23 August 2007 Application Accepted

  Published as AU-B-2002325711

3 January 2008 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 30 Nov 2007. Address for service in Australia - Shelston IP Level 21 60 Margaret Street Sydney NSW 2000

24 January 2008 Standard Patent Sealed

29 May 2008 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 30 Nov 2007

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002325712-Differentiation of neural stem cells and therapeutic use theeof

2002325710-EFFECT OF GROWTH HORMONE AND IGF-1 ON NEURAL STEM CELLS